Community Pharmacies

Rachel Gilmour Excerpts

Tuesday 2nd June 2026 Westminster Hall

[Rachel Gilmour (Tiverton and Minehead) (LD)]

I beg to move,

That this House has considered the future of community pharmacies.

It is always a pleasure to see the Minister in his place. I know how committed he is to his brief, and I am grateful for the conversations we have had on a number of important issues. The timing of this debate could hardly be better, coming as it does in the wake of the Government’s announcement just before the weekend. That announcement provides the perfect context within which to couch my remarks. I would like to believe that I have developed a reputation for constructive criticism, and I hope to offer a fair-minded but frank scrutiny of the Government’s plans for community pharmacies. There are positive moves, which I welcome, but there is also considerably further to go.

It is clear that the national picture for community pharmacies is one of an incredibly fragile system, and I am sure that much reference will be made this morning to the damning headline statistic that since 2016, over 1,000 pharmacies have been lost across England. Funding was cut that same year and remained flat in cash terms until 2024, even as the volume of NHS pharmaceutical care and the cost of providing it surged.

[Mr Gagan Mohindra (South West Hertfordshire) (Con)]

I congratulate the hon. Member on securing the debate. When I met the Minister in April, we were going through the consultation on the pharmacy contract, but we are yet to hear any announcement. Does the hon. Member agree that the pharmacies we all rely on need certainty about when their contract negotiations and the associated funding will be completed?

[Rachel Gilmour]

The hon. Member makes a good point, which I shall return to in due course.

The community pharmacy network has had to absorb real-terms cuts of 30% in Government funding. For most community pharmacies, NHS funding accounts for 90% to 95% of their annual income. That is simply not a sustainable business model; it is a slow strangulation. The Government’s own independent economic analysis, published as recently as March this year, found the gap to be £2 billion a year. More recently still, the Government have admitted that pharmacies in England were funded £800 million less in real terms in 2025-26 than they were a decade ago. It is important to be clear that those are the Government’s own figures.

Against that backdrop, I welcome the funding settlement for 2026-27.

[Claire Hazelgrove (Filton and Bradley Stoke) (Lab)]

As a fellow south-west MP, will the hon. Lady welcome the fact that the Minister came to the Concord pharmacy in Little Stoke in my constituency just last week to make the welcome announcement about £340 million more to boost our vital community pharmacies? Does she agree that when the Minister winds up, it would be helpful for him to share how he finds these visits valuable in forming his work in the Department and showing him more about the support that pharmacies need?

[Rachel Gilmour]

As I said at the beginning, the Minister is a very hands-on Minister, and I am sure he finds every visit absolutely fascinating.

The community pharmacy budget will increase by 10.3% to £3.636 billion. The introduction of independent prescribing into some pharmacy services later this year is a positive step, as are the measures aimed at stabilising the volatile medicines supply system. In the spirit of constructive opposition, I will certainly give credit where credit is due, but we must be honest: the settlement is still far short of what pharmacies need to keep their doors open. Over 600 branches closed last year alone.

[Adam Dance (Yeovil) (LD)]

Pharmacists such as Max, who runs South Petherton pharmacy, are taking care of constituents from the other side of my constituency. Our pharmacies in rural areas are expected to do more and more with little extra help. Does my hon. Friend agree that alongside greater funding, we need to see the Government use the NHS workforce plan to properly expand the pharmacy workforce?

[Rachel Gilmour]

As a rural MP myself, I certainly have a grasp of what my hon. Friend addresses, and I shall come to that in a minute.

Analysis conducted by the Independent Pharmacies Association shows that an average pharmacy dispensing around 10,000 items a month will face a shortfall of approximately £56,000, even after the settlement. Without a commitment to continued above-inflation funding increases year on year, patients will face an acceleration of service reductions and closures. Those closures will fall hardest on communities such as mine and that of my hon. Friend, as I will explain.

My constituents have lived with these difficulties. At a cursory glance, there are 16 pharmacies across Tiverton and Minehead, serving a population of approximately 91,200. On average, they dispense 113,000 prescriptions every month because they are busy, essential, community institutions. Yet a survey of 3,000 people in Tiverton, conducted by a local GP surgery, found that 30% of respondents were unable to find a pharmacy. That should simply not be the case in 21st-century Britain. It cuts to the heart of a fundamental truth about rural healthcare and much more that successive Governments have neglected to confront.

[Lee Pitcher (Doncaster East and the Isle of Axholme) (Lab)]

I recently visited Weldricks pharmacy in Rossington and saw the amazing work done by the team there. My constituency is in quite a rural area and provision is patchy. Does the hon. Member agree that it would be good to map all community pharmacies, understand where there are gaps, and make targeted interventions? That would ensure provision for the number of people living in that area.

[Rachel Gilmour]

I agree that a strategic approach is always best. The distances, the limited public transport and the dispersed nature of rural populations mean that the closure of a single pharmacy can represent a genuine healthcare crisis for thousands of people. I see that directly in my constituency; the loss of a fully fledged pharmacy with all its associated services in Bishops Lydeard in March 2024 was a blow to the community. In its place there is now a dispensary, but solely for patients of the surgery. The same thing happened in Norton Fitzwarren. Transport woes, which so often hold back my constituents, sever a vital link to the health service.

Jhoots, the previous provider of pharmacy services in parts of Tiverton and Minehead, had operated poorly for some time. Constituents lamented the missing medicines, unexpected closures and queues stretching down the street. Under the new stewardship of Allied Pharmacies, things have improved markedly. That is a testament to what good management and proper investment can achieve.

[Edward Morello (West Dorset) (LD)]

My hon. Friend raises the spectre of Jhoots, which resulted in the closure of the Bridport and Lyme Regis pharmacies in my constituency. Jhoots exposed serious concerns around contractual failures, unsafe practices, staff treatment and service continuity, leaving staff in my constituency relying on food banks. When I met the Minister, he told me that officials were reviewing whether additional regulatory powers were required to prevent another Jhoots scandal. Does my hon. Friend agree that it is important for the Government to bring forward legislation to deal with such a scenario?

[Rachel Gilmour]

I have had that discussion with the Minister, who reassured me that the Jhoots scenario has been at the front of his mind and he will seek to resolve it.

There is also the question of business rates. It seems manifestly unfair that community pharmacies, which are frontline NHS providers in every meaningful sense, are required to pay full business rates, while GP surgeries and dental practices do not face the same burden. I ask the Minister how that disparity can be justified and whether the Government intend to address that.

Pharmacies are the engine of community care and offer an opportunity that the Government have not fully grasped. The thrust of the Government’s health strategy has been care in the community, devolving healthcare back to local settings, with neighbourhood health structures and a shift away from hospitals to primary and preventive care. All of that is absolutely right but cannot be delivered without the community pharmacy network. Pharmacies are already doing the work the Government say they want the NHS to do: local, preventive, accessible care, delivered by trusted professionals in the heart of communities. The funding must match the words.

[Amanda Hack (North West Leicestershire) (Lab)]

The hon. Member is making a powerful speech about the importance of community pharmacy. There are pharmacies on the edge of my constituency, serving Leicestershire, Nottinghamshire and Derbyshire. The inconsistency of integrated care board delivery can create problems for local communities trying to get medicines. Does the hon. Member agree that we need consistency of approach?

[Rachel Gilmour]

I assure the hon. Lady that some of the most frustrating conversations I have are with my local ICBs. Properly resourced pharmacies could release a staggering 51 million primary care appointments through an expanded Pharmacy First service, prevention services and a greater role in managing long-term conditions. That is 51 million appointments freed up in general practice, allowing more people to escape the infamous 8 am scramble. Pharmacies often meet people where they are, offering more accessible services to those who might not otherwise engage with the health service at all. They are arguably the most accessible arm of the NHS.

[James Naish (Rushcliffe) (Lab)]

I have been fortunate to have a pathfinder within the independent prescribing programme in my constituency. Its data shows that only 5% of patients who use the independent prescribing pathway need to be referred to their GP, so it is exactly as she says: there are huge savings to be made. I must push the Minister, because Community Pharmacy England has said that it is

“not persuaded that sufficient investment is being made to enable the full and effective introduction of independent prescribing.”

Does the hon. Lady agree that the Minister should look at that carefully to make sure that we are getting as much as we can out of community pharmacy?

[Rachel Gilmour]

I shall come to just that point in a minute. This sounds strange now, but I am going to say it: take obesity, for example. One in three people in the UK are currently classified as obese. Obesity is estimated to cost the NHS over £11.4 billion a year, with wider societal costs to the tune of £74 billion a year. Community pharmacies are ideally placed to provide wraparound support for those prescribed weight-loss medicines as part of an NHS-commissioned service, but they need the resources and the commissioning framework to do so.

There is one aspect of this debate that receives insufficient attention, and I want to raise it briefly. The ongoing situation in the middle east has hit the pharmaceutical supply chain as much as any other sector. There were a record 219 price concessions announced for community pharmacies in May alone, with further negotiations still ongoing. The cost of medicines has risen sharply. I understand that some cancer drugs have reportedly seen elevenfold increases. Crucially, medicine shortages and record-high price concessions reflect an instability in the supply chain that is being intensified by geopolitical pressures. I put it to the Government that the growing medicine supply crisis poses serious risks to Britain’s preparedness and resilience.

[Hannah Spencer (Gorton and Denton) (Green)]

I met with a pharmacy manager in Denton who told me that NHS reimbursement for medicines is not keeping pace with rising costs. They are dispensing medicines at a loss, paying more to suppliers than the NHS then reimburses them and absorbing the shortfall. Does the hon. Lady agree that independent pharmacies need to be fairly funded if they are to continue acting as the front door to the NHS?

--- Later in debate ---

[Rachel Gilmour]

I agree wholeheartedly.

I want to turn to two issues that I consider to be the systemic failures underlying all others: workforce and integration. On workforce, the community pharmacy network lost 3,000 full-time equivalent pharmacists between 2021 and 2025. That is not a sustainable trajectory. There is a specific incoherence in current policy that I must name. If one arm of the national health service is funded to recruit pharmacists away from community pharmacy while community pharmacies are simultaneously expected to take pressure off the same system, that is not joined-up workforce planning; it is quite simply the left hand not knowing what the right hand is doing.

The introduction of independent prescribing is laudable and long overdue, and I note that it is expected to come later this year, but I ask for more specificity from the Minister. What is the Government’s current timetable for making independent prescribing a routine, commissioned part of NHS community pharmacy services? If we train pharmacists to prescribe and then fail to commission services that let them do so in community settings, we will have wasted a major opportunity, and we will have trained a cohort of professionals whose skills are systematically underused.

On integration, Pharmacy First will not reach its full potential if GPs, hospitals, NHS 111 and patients all have a different understanding of how it functions. The incongruence within the system is hobbling pharmacy practice. What is required is proper system-wide integration, with pharmacies recognised as a fundamental pillar of our NHS. As the NHS modernisation Bill progresses through Parliament, that must be recognised. 

Pharmacies are already doing the work that the Government say they want the NHS to do. They are the first port of call, the most accessible point of contact and the trusted face of healthcare on high streets and in rural communities across this country. The Government have taken some positive steps, and I reiterate that the 10.3% uplift is very important. The direction of travel towards community care, independent prescribing and neighbourhood health is right, but direction without sufficient resource is just aspiration.

[Manuela Perteghella (Stratford-on-Avon) (LD)]

Although I also welcome the funding uplift, community pharmacies were already in crisis after years of real-term funding cuts, especially in rural areas. Does my hon. Friend agree that the Government need to scrap unfair budgetary pressures on community pharmacies and commit to a funding model that will put them on a sustainable financial footing for years to come?

[Rachel Gilmour]

Of course, I fully agree with my hon. Friend’s comments, and I laud her good work in her constituency. I urge the Government to commit to above-inflation funding increases year on year in order to close the £2 billion gap identified by their own independent analysis, deliver proper integration across the NHS and address the workforce crisis before it becomes irreversible. Pharmacies are ready, they are willing and they are already delivering. The question is whether the Government will match that commitment with the funding and the strategy that the sector and our constituents deserve. I look forward to hearing hon. Members’ contributions.

--- Later in debate ---

[Rachel Gilmour]

I do not have time to go through the list of hon. Friends and hon. Members who have made fantastic contributions. Suffice it to say that there is only one negative aspect of this debate: the fact that not a single Conservative Member of Parliament is here is shocking.

I just want to say happy birthday to the hon. Member for Dunstable and Leighton Buzzard (Alex Mayer). I do not suppose she imagined that she would start her birthday by debating community pharmacies, but I hope she has a wonderful day.

Question put and agreed to.

Resolved,

That this House has considered the future of community pharmacies.